Skip to main content
Journal ArticleOPEN ACCESS

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery

  • Eriksson B
  • Bauer K
  • Lassen M
  • et al.
New England Journal of Medicine (2001) 345(18) 1298-1304
DOI: 10.1056/nejmoa011100
665Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

Abstract

Surgery for hip fracture carries a high risk of venous thromboembolism, despite the use of current thromboprophylactic treatments. Fondaparinux, a synthetic pentasaccharide, is a new antithrombotic agent that may reduce this risk.

Cite

CITATION STYLE

APA

Eriksson, B. I., Bauer, K. A., Lassen, M. R., & Turpie, A. G. G. (2001). Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery. New England Journal of Medicine, 345(18), 1298–1304. https://doi.org/10.1056/nejmoa011100

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free